FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...

There were an estimated 47 million to 82 million flu illnesses in the United States between October 2024 and May 2025.

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...

The vaccine requires a prescription, which people can obtain by filling out a medical screening questionnaire through the ...

Influenza infections are emerging as the primary driver behind the recent surge in viral fever cases across the country, with ...

Parenting guidance isn’t set in stone — it evolves with the science and the times. An expert outlines five practices that ...

Remote-work flexibility has supported workplace equity helped limit outbreaks of respiratory infections. Back-to-offices ...

Canadian employers have been mandating workers back to in-person work through blanket return-to-office policies. On top of harming workplace equity ...

Australian shares are set to open lower this morning after US stocks ended roughly flat overnight, as local traders await ...

From that haphazard beginning, the cemetery grew into the final resting place of the Creston Valley’s earliest settlers. In ...

The FDA has approved an at-home nasal spray flu vaccine, and it’s now available for order. FluMist enters the bloodstream ...